NxStage Medical Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
263,429.00
301,501.00
336,123.00
366,378.00
393,941.00
Cost of Goods Sold (COGS) incl. D&A
161,582.00
185,340.00
202,381.00
211,526.00
226,071.00
Gross Income
101,847.00
116,161.00
133,742.00
154,852.00
167,870.00
SG&A Expense
120,301.00
138,090.00
146,100.00
156,270.00
176,239.00
EBIT
18,454.00
21,929.00
12,884.00
1,875.00
8,814.00
Unusual Expense
-
-
-
500.00
6,200.00
Non Operating Income/Expense
259.00
268.00
1,184.00
2,840.00
300.00
Interest Expense
611.00
863.00
1,115.00
1,000.00
756.00
Pretax Income
18,806.00
23,060.00
15,183.00
6,215.00
15,470.00
Income Tax
245.00
1,253.00
1,077.00
1,102.00
145.00
Consolidated Net Income
18,561.00
24,313.00
16,260.00
7,317.00
15,325.00
Net Income
18,561.00
23,946.00
15,342.00
4,771.00
14,473.00
Net Income After Extraordinaries
18,561.00
23,946.00
15,342.00
4,771.00
14,473.00
Net Income Available to Common
18,561.00
23,946.00
15,342.00
4,771.00
14,473.00
EPS (Basic)
0.31
0.39
0.24
0.07
0.22
Basic Shares Outstanding
60,261.00
61,700.00
63,384.00
64,520.00
65,856.00
EPS (Diluted)
0.31
0.39
0.24
0.07
0.22
Diluted Shares Outstanding
60,261.00
61,700.00
63,384.00
64,520.00
65,856.00
EBITDA
6,394.00
5,768.00
17,831.00
30,762.00
25,586.00
Other Operating Expense
-
-
526.00
457.00
445.00
Minority Interest Expense
-
367.00
918.00
2,546.00
852.00
About NxStage Medical
View Profile
